Liquid Web Launches Scalable Disaster Recovery Solutions for VMware with Acronis
Predictable fixed monthly fee, seamless VMware integration, and white-glove implementation are key differentiators of Liquid Web’s offering. ATLANTA, March... Read more.
CGI expands its presence in Québec City with the acquisition of Momentum Technologies
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom Acquisition deepens CGI’s data and business intelligence capabilities MONTRÉAL, March 25, 2025... Read more.
Kulicke & Soffa Introduces Asterion®-PW for Power Semiconductor Applications
Redefining Pin Interconnect Technology with Sonotrode™ SINGAPORE, March 25, 2025 /PRNewswire/ — Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke... Read more.
Health in Tech Expands Access to Virtual Care Through Collaboration with DialCare
STUART, Fla., March 25, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to... Read more.
Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in a Clinical Plenary Oral Presentation at AACR 2025
Data to be presented from the STARt-001 trial demonstrating single agent anti-tumor activity CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ — Marengo Therapeutics,... Read more.
Velo3D to Announce Fiscal Year 2024 Results on March 31, 2025
FREMONT, Calif., March 25, 2025 /PRNewswire/ — Velo3D, Inc. (OTC: VLDX) — a leader in additive manufacturing (AM) technology known for transforming aerospace... Read more.
Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025
— Abstract accepted for late-breaking poster presentation – — EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of... Read more.
Kulicke & Soffa Introduces New Vertical Wire Solutions to Expand Market Leadership
Elevating Memory Density with ATPremier MEM PLUS™ SINGAPORE, March 25, 2025 /PRNewswire/ — Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke... Read more.
Accent Therapeutics to Present Data on Lead Programs ATX-559 and ATX-295 at the 2025 American Association for Cancer Research Annual Meeting
Preclinical data reinforce therapeutic potential of ATX-559, a first-in-class oral DHX9 inhibitor, in cancers characterized by genomic instability and replication... Read more.
Rgenta Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) 2025 Annual Meeting
WOBURN, Mass., March 25, 2025 /PRNewswire/ — Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral... Read more.